Andere Sprachen PharmaResearch Co., Ltd.

Aktien

A214450

KR7214450009

A214450

Schlusskurs Korea S.E. Andere Börsenplätze 00:00:00 26.04.2024			% 5 Tage	% 1. Jan.
118’800 ^KRW	+4.85%		-8.26%	+8.49%

2023

PharmaResearch Co. Ltd. meldet Ergebnis für das am 31. Dezember 2022 endende Geschäftsjahr

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

PharmaResearch Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	22.03.23
PharmaResearch acquires patent registration on bone grafting composition in China	25.05.22
High Concentration Nucleic Acid Liquid Composition Patent Registration is Confirmed in Japan	06.05.22
PharmaResearch Participates in South Korea's Largest Medical Exhibition - KIMES 2022	21.03.22
PharmaResearch acquires a patent for filler composition for molding filling composition for tissue enhancement	21.12.21
PHARMA RESEARCH BIO Co., Ltd. announced that it has received KRW 30 billion in funding from PharmaResearch Co., Ltd.	26.11.21
PharmaResearch Acquires Medicoson, Medical Electronics Company	24.11.21
PHARMA RESEARCH BIO Co., Ltd. announced that it expects to receive KRW 30 billion in funding from PharmaResearch Co., Ltd.	24.11.21
PharmaResearch Co., Ltd. acquired Medicoson Co., Ltd.	24.11.21
PharmaResearch Co., Ltd. announced that it has received KRW 25 billion in funding from NH Investment & Securities Co., Ltd., Investment Arm	28.10.21
PharmaResearch Co., Ltd. announced that it expects to receive KRW 25 billion in funding from NH Investment & Securities Co., Ltd., Investment Arm	26.10.21
PharmaResearch : acquires Japanese patent for articular cavity injection comprising nucleic acid and chitosan	27.08.21
Tranche Update on Pharma Research Products Co., Ltd's Equity Buyback Plan announced on February 21, 2019.	21.02.20
Tranche Update on Pharma Research Products Co., Ltd's Equity Buyback Plan announced on February 21, 2019.	21.02.20
Tranche Update on Pharma Research Products Co., Ltd's Equity Buyback Plan announced on February 21, 2019.	21.02.20
Tranche Update on Pharma Research Products Co., Ltd's Equity Buyback Plan announced on February 21, 2019.	21.02.20
Pharma Research Products Co., Ltd's Equity Buyback announced on February 21, 2019, has expired with 129,237 shares, representing 1.37% for KRW 4,992.18 million.	21.02.20
Pharma Research Products Co., Ltd's Equity Buyback Plan Extended till February 21, 2020.	21.08.19
Tranche Update on Pharma Research Products Co., Ltd's Equity Buyback Plan announced on February 21, 2019.	22.05.19
Pharma Research Products Co., Ltd announces an Equity Buyback for KRW 5,000 million worth of its shares.	21.02.19

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen PharmaResearch Co., Ltd.

Aktien

A214450

KR7214450009

A214450

Andere Sprachen

Filter